Abacus Health Products

CN: ABCS

Market CapC$78.1m

Last Close C$6.51

Abacus Health Products is a consumer healthcare company that is combining cannabidiol with active ingredients that have known efficacy to provide relief from those suffering from pain, itch and acne, among other indications.

More Abacus Health Products content >

Investment summary

Edison Investment Research is terminating coverage on Abacus Health Products (ABCS), ADL Bionatur (BNT), ASIT Biotech (ASIT), GAME Digital (GMD), International Stem Cell Corporation (ISCO), Powerhouse Energy Group (PHE), Windar Photonics (WPHO). Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Dec
Revenue (US$m)
EBITDA (US$m)
PBT (US$m)
EPS (c)
P/E (x)
P/CF (x)
2018A 8.5 1.0 0.6 4.32 109.1 73.9
2019A 15.5 (17.6) (17.7) (90.46) N/A N/A
2020E 29.2 (6.1) (6.5) (28.95) N/A N/A
2021E 78.3 22.5 22.1 74.74 6.3 5.5
Content on Abacus Health Products
Abacus Health Products – Strong 2019 growth
Healthcare | Update | 30 April 2020
Executive interview – Abacus Health Products
Healthcare | Edison TV | 9 January 2020
 
Abacus Health Products – Strong Q3 sales
Healthcare | Update | 26 November 2019
View more
Register to receive research on Abacus Health Products as it is published
Share price graph
Balance sheet
Forecast net cash (US$m) 23.4
Forecast gearing ratio (%) N/A
Price performance
%
1m
3m
12m
Actual 48.3 69.1 (31.1)
Relative* 48.8 60.3 (25.6)
52-week high/low C$10.8/C$2.8
*% relative to local index
Key management
Perry Antelman CEO
Henry (Hank) Hague, III FD